The number of high-risk factors is related to outcome in stage II colonic cancer patients

European Journal of Surgical Oncology

Volumn 37, Issue 11, 2011, Pages 964-970

  Koebrugge, B ^a   Vogelaar, F J ^a   Lips, D J ^a   Pruijt, J F ^a   Van Der Linden, J C ^a   Ernst, M F ^a   Bosscha, K ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Chemotherapy; Colonic cancer; High risk; Outcome; Survival; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 80053639802     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.08.135     Document Type: Article

References (23)

1. Association of Comprehensive Cancer Centres. www.ikcnet.nl.
2. Dutch guideline 'Colonic cancer' 2008 http://www.cbo.nl/Downloads/326/rl- colonc-08.pdf
3. V.C. Petersen, K.J. Baxter, S.B. Love, and N.A. Shepherd Identification of objective pathological prognostic determinants and models of prognosis in Dukes'B colon cancer Gut 51 2002 65 69 (Pubitemid 34717746)
4. E.J.A. Morris, N.J. Maughan, D. Forman, and P. Quirke Who to treat with adjuvant chemotherapy in Dukes B/stage II colorectal cancer? The need for high quality pathology Gut 56 2007 1419 1425 (Pubitemid 47517838)
5. Y.J. Park, K.J. Park, J.G. Park, K.U. Lee, K.J. Choe, and J.P. Kim Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases World J Surg 23 1999 721 726 (Pubitemid 29314417)
6. H. Quah, J.F. Chou, and M. Gonen Identification of patients with high-risk stage II colon cancer for adjuvant therapy Dis Colon Rectum 51 2008 503 508
7. M. Morris, C. Platell, and K. McCaul Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting Int J Colorectal Dis 22 2007 887 895 (Pubitemid 46952037)
8. K.Y. Tan, F. Konishi, and K. Suzuki The evidence for adjuvant treatment of elderly patients (age > or = 70) with stage III colon cancer is inconclusive Surg Today 40 2010 385 387
9. N.L. Keating, M.B. Landrum, and C.N. Klabunde Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol 26 2008 May 20 2532 2537
10. Registry of federally and privately supported clinical trials. www.clinicaltrials.gov.
11. W. Kelder, B. Inberg, and M. Schaapveld Impact of the number of histologically examined lymph nodes on prognosis in colon cancer; a population-based study in the Netherlands Dis Colon Rectum 52 2009 260 267
12. G. Cserni, V. Vinh-Hung, and T. Burzykowski Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 81 2002 63 69
13. F. Cianchi, A. Palomba, and V. Boddi Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined World J Surg 26 2002 384 389 (Pubitemid 36920420)
14. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American joint committee on cancer sixt editing staging J Nat Cancer Inst 96 2004 1420 1425 (Pubitemid 39429665)
15. C. Lin, J. Lin, and S. Chang Is adjuvant therapy beneficial to high risk stage II colon cancer? Analysis in a single institute Int J Colorectal Dis 24 2009 665 767
16. ASCO guideline colonic cancer. http://www.asco.org/portal/site/ascov2.
17. IMPACT B2 Investigators Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer J Clin Oncol 17 1999 1356 1363 International Multicentre Pooled Analysis of B2 Colon Cancer Trials
18. S. Gill, C.L. Loprinzi, and D.J. Sargent Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 2004 1797 1806 (Pubitemid 41095169)
19. Quasar collaborative group Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 37 2007 2020 2029
20. D. Iddings, A. Ahmad, D. Elashoff, and A. Bilchik The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta- analysis Ann Surg Oncol 13 2006 1386 1392 (Pubitemid 44749649)
21. P.M. van Schaik, E. Hermans, J.C. van der Linden, J.R. Pruijt, M.F. Ernst, and K. Bosscha Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survival Eur J Surg Oncol 35 2009 492 496
22. A. Bilchik, A. Nissan, and Z. Wainberg Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer Ann Surg 252 2010 467 476
23. P.G. Horgan, and D.C. McMilan Surgeons and selection of adjuvant therapy for node-negative colonic cancer BJS 97 2010 1459 1460